Myeloblastic neoplasms occur in patients with leukemia. In women, the ovary is a common site. The cells of the tumor are identical histochemically to those in the peripheral blood. The Giemsa stain, PAS stain, and Leder stain assist in the diagnosis. The tumors are responsive to radiation therapy, chemotherapy, and operative removal, but tend to be associated with decreased survival. This report describes a case of myeloblastoma of the ovary in an 18-year-old woman. The clinical and pathologic features of these tumors are described. The literature is reviewed briefly.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Myeloid Sarcoma Mimicking Dental Abscess in a Patient with Chronic Myeloid Leukemia: Diagnostic and Therapeutic Dilemma.
Case Rep Oncol
August 2022
Department of Hematology and Medical Oncology, Hamad Medical Corporation, Doha, Qatar.
Chronic myeloid leukemia (CML) is a hematologic malignancy that has significant improvement in its prognosis after the introduction of tyrosine kinase inhibitors. Transformation to accelerated phase or blast phase can happen. Myeloid sarcoma or chloroma is an uncommon extramedullary disease.
View Article and Find Full Text PDFEarly Ophthalmological Manifestations of Acute Myeloid Leukemia: Current Perspectives.
Clin Ophthalmol
July 2022
Ophthalmology Department, American University of Beirut Medical Center, Beirut, Lebanon.
Acute myeloid leukemia (AML) is a hematological malignancy affecting different organ systems including the eye. The purpose of this review is to present and evaluate the medical literature regarding the early ophthalmological manifestations of acute myeloid leukemia. AML affects the ocular system through direct infiltration of tissues, secondary to hematological abnormalities, or in the form of chloroma or myeloid sarcoma in the brain or orbit consequently leading to a variety of manifestations depending on the ocular tissue involved.
View Article and Find Full Text PDFIsolated Myeloid Sarcoma: A Diagnostic Dilemma.
Cureus
January 2022
Hematology and Medical Oncology, East Carolina University, Greenville, USA.
Myeloid sarcoma (MS)/granulocytic sarcoma/myeloblastoma/chloroma is a rare extramedullary proliferation of blast cells of one or more myeloid lineages along with the destruction of the normal architecture of adjacent tissue. Isolated MS is a rare entity with an incidence of 0.7 out of 1 million children and 2 out of 1 million adults.
View Article and Find Full Text PDFIsolated myeloid sarcoma of lumbar spine without bone marrow involvement: a rare case report and treatment dilemma.
AME Case Rep
July 2021
Department of Hematology and Oncology, Kern Medical Center-UCLA, Bakersfield, CA, USA.
Granulocytic sarcoma, chloroma, myeloblastoma, or here referred as myeloid sarcoma (MS), is a rare extramedullary tumor composed of immature myeloid cells called myeloblasts. MS is seen most commonly in patients with acute myeloid leukemia and less frequently in chronic myeloid leukemia, myelodysplastic syndrome. In rarer instances, MS has been shown to precede the development of myeloid tumors by acute myeloblastic leukemia (AML).
View Article and Find Full Text PDFClinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.
Hematology
January 2018
b Division of Hematology and Oncology , Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock , AR , USA.
Background: Myeloid sarcoma (MS) is characterized by extramedullary infiltration by immature myeloid cells. Owing to rarity of this disease, the clinical features and overall outcomes are yet to be clarified.
Objective: To define clinical characteristics, epidemiology, pathologic findings, treatment options and outcomes in MS.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!